Skip to main content
. 2020 Apr 15;20:72. doi: 10.1186/s12893-020-00739-2

Table 3.

Comparison of postoperative parameters between HA and non-HA groups

Parameters HA(n = 61) non-HA(n = 102) P value a
EPPH 3 2 0.360
EPPH treatment 1.000
 Non-surgical therapy 2 1
 Reoperation 1 1
LPPH 4 5 0.729
LPPH treatment
 Conservation 1 3 0.539
 Intervention 1 1
 Surgery 2 1
POPF 12 18 0.747
POPF grade 0.076b
 A 6 14
 B 2 3
 C 4 1
Biliary fistula 1 4 0.651
DGE Grade C 2 3 1.000
Hyperbilirubinemia 4 6 1.000
Infection complications 20 29 0.557 c
Infection site
 Incision 15 15 0.079 c
 Lung 1 0
 Intra-abdominal 4 14
Ascites 26 35 0.289c
Ascites severity
 Mild 14 25 0.157c
 Middle 12 10
Postoperative delirium 3 1 0.148
Cardiovascular events 1 0 0.374
Liver dysfunction 2 0 0.139
Upper gastrointestinal hemorrhage 5 5 0.503
Lower gastrointestinal hemorrhage 1 0 0.374
Multiorgan dysfunction 2 1 0.557
Clavien-Dindo classification 0.020b
 0 28 61
 I 11 25
 II 12 6
 IIIa 2 5
 IIIb 2 4
 IVa 2 0
 IVb 0 0
 V 4 1
Reoperation 2 4 1.000
Postoperative ALB infusion dosage(g) * 169.0 ± 126.1 115.6 ± 87.9 0.186 d
Postoperative ALB infusion frequency* 10.7 ± 6.9 5.81 ± 4.0 0.365d
Somatostatin application (day) * 9.3 ± 4.2 10.1 ± 3.8 0.215 d
Postoperative pRBC transfusion(U) * 4.3 ± 3.1 4.0 ± 1.9 0.003 d
Postoperative plasma transfusion (ml) * 869.0 ± 633.8 545.9 ± 373.1 0.086 d
Hospital stay (days) * 30.0 ± 13.6 29.2 ± 13.4 0.658 d
30-day Mortality 2 1 0.557
60-day Mortality 4 1 0.066

a: Fisher’s exact test; b: Wilcoxon rank sum test; c: Pearson x2test; d: Mann-Whitney U test

Abbreviations: EPPH early postpancreatectomy hemorrhage, LPPH Late postpancreatectomy hemorrhage

* expressed as Mean ± SD